Validation of the SF-6D Health State Utilities Measure in Lower Extremity Sarcoma.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 3977426)

Published in Sarcoma on March 19, 2014

Authors

Kenneth R Gundle1, Amy M Cizik1, Stephanie E W Punt1, Ernest U Conrad1, Darin J Davidson1

Author Affiliations

1: Department of Orthopaedics & Sports Medicine, University of Washington Medical Center, 1959 Pacific Street NE, Box 356500, Seattle, WA 98195, USA.

Articles citing this

Desmoid fibromatosis: MRI features of response to systemic therapy. Skeletal Radiol (2016) 0.83

Articles cited by this

EuroQol: the current state of play. Health Policy (1996) 27.78

The MOS short-form general health survey. Reliability and validity in a patient population. Med Care (1988) 21.00

The estimation of a preference-based measure of health from the SF-36. J Health Econ (2002) 14.18

Measurement of health state utilities for economic appraisal. J Health Econ (1986) 11.70

US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care (2005) 9.89

A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ (2004) 4.42

Development of a measure of physical function for patients with bone and soft tissue sarcoma. Qual Life Res (1996) 3.40

Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. J Clin Oncol (2012) 2.82

A comparative review of four preference-weighted measures of health-related quality of life. J Clin Epidemiol (2003) 1.97

Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Med Care (2007) 1.87

Modelling SF-6D health state preference data using a nonparametric Bayesian method. J Health Econ (2006) 1.40

The 36-item short form. J Am Acad Orthop Surg (2007) 1.30

A review of generic preference-based measures of health-related quality of life in visual disorders. Value Health (2011) 1.24

Comparing cost-utility estimates: does the choice of EQ-5D or SF-6D matter? Med Care (2009) 1.15

Estimating health utilities in patients with asthma and COPD: evidence on the performance of EQ-5D and SF-6D. Qual Life Res (2008) 1.08

The potential economic benefits of improved postfracture care: a cost-effectiveness analysis of a fracture liaison service in the US health-care system. J Bone Miner Res (2014) 1.08

Systematic review and empirical comparison of contemporaneous EQ-5D and SF-6D group mean scores. Med Decis Making (2011) 1.05

Feasibility of internet-based health-related quality of life data collection in a large patient cohort. J Med Internet Res (2010) 0.92

Cost effectiveness of denosumab versus oral bisphosphonates for postmenopausal osteoporosis in the US. Appl Health Econ Health Policy (2013) 0.84

The SF-6D health utility index in carpal tunnel syndrome. J Hand Surg Eur Vol (2007) 0.82